Identical gene regulation patterns of T3 and selective thyroid hormone receptor modulator gC-1
Open accessAbstract
Synthetic selective thyroid hormone (TH) receptor (TR) modulators (STRM) exhibit beneficial effects on dyslipidemias in animals and humans and reduce obesity, fatty liver, and insulin resistance in preclinical animal models. STRM differ from native TH in preferential binding to the TRβ subtype vs. TRα, increased uptake into liver, and reduced uptake into other tissues. However, selective modulators of other nuclear receptors exhibit important gene-selective actions, which are attributed to differential effects on receptor conformation and dynamics and can have profound influences in animals and humans. Although there are suggestions that STRM may exhibit such gene-specific actions, the extent to which they are actually observed in vivo has not been explored. Here, we show that saturating concentrations of the main active form of TH, T(3), and the prototype STRM GC-1 induce identical gene sets in livers of euthyroid and hypothyroid mice and a human cultured hepatoma cell line that only expresses TRβ, HepG2. We find one case in which GC-1 exhibits a modest gene-specific reduction in potency vs. T(3), at angiopoietin-like factor 4 in HepG2. Investigation of the latter effect confirms that GC-1 acts through TRβ to directly induce this gene but this gene-selective activity is not related to unusual T(3)-response element sequence, unlike previously documented promoter-selective STRM actions. Our data suggest that T(3) and GC-1 exhibit almost identical gene regulation properties and that gene-selective actions of GC-1 and similar STRM will be subtle and rare.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Selective modulation of THR-β1 allows targeting hepatic genes without cardiac side effects.
“Selective modulation of THR-β1 allows targeting hepatic genes without cardiac side effects.181 182”
From Novel therapeutic targets for cholestatic and fatty liver disease (2022) · cites this paper as [181]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
The coregulator exchange in transcriptional functions of nuclear receptors
Glass, C. K., & Rosenfeld, M. G. (2000) · Genes & Development · doi:10.1101/gad.14.2.121 · Cited by 2,233 · see citing works
Physiological and Molecular Basis of Thyroid Hormone Action
Yen, P. M. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.3.1097 · Cited by 2,011 · see citing works
Nuclear Receptor Expression Links the Circadian Clock to Metabolism
Yang, X., Downes, M., Yu, R. T., Bookout, A. L., He, W., Straume, M., Mangelsdorf, D. J., & Evans, R. M. (2006) · Cell · doi:10.1016/j.cell.2006.06.050 · Cited by 934 · see citing works
Samuels, H. H., Stanley, F. M., & Casanova, J. (1979) · Endocrinology · doi:10.1210/endo-105-1-80 · Cited by 649 · see citing works
Use of the Thyroid Hormone Analogue Eprotirome in Statin-Treated Dyslipidemia
Ladenson, P. W., Kristensen, J. D., Ridgway, E. C., OLSSON, A. G., Carlsson, B., Klein, I. L., Baxter, J. D., & Angelin, B. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0905633 · Cited by 337 · see citing works
Self-citationFunctions of Thyroid Hormone Receptors in Mice
Forrest, D., & Vennström, B. (2000) · Thyroid · doi:10.1089/thy.2000.10.41 · Cited by 298 · see citing works
Erion, M. D., Cable, E. E., Ito, B. R., Jiang, H., Fujitaki, J. M., Finn, P. D., Zhang, B., Hou, J., Boyer, S. H., van Poelje, P. D., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702759104 · Cited by 273 · see citing works
Trost, S. U., Swanson, E., Gloss, B. R., Wang‐Iverson, D. B., Zhang, H., Volodarsky, T., Grover, G. J., Baxter, J. D., Chiellini, G., Scanlan, T. S., et al. (2000) · Endocrinology · doi:10.1210/endo.141.9.7681 · Cited by 268 · see citing works
Self-citationThyroid hormone mimetics: potential applications in atherosclerosis, obesity and type 2 diabetes
Baxter, J. D., & Webb, P. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2830 · Cited by 253 · see citing works
Self-citationGrover, G. J., Mellström, K., Liu, Y., Malm, J., Li, Y., Bladh, L.-G., Sleph, P. G., Smith, M. A., George, R. J., Vennström, B., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1633737100 · Cited by 221 · see citing works
Self-citationCable, E. E., Finn, P. D., Stebbins, J. W., Hou, J., Ito, B. R., van Poelje, P. D., Linemeyer, D. L., & Erion, M. D. (2008) · Hepatology · doi:10.1002/hep.22572 · Cited by 206 · see citing works
Estrogen receptors: selective ligands, partners, and distinctive pharmacology.
Katzenellenbogen, B. S., Montano, M. M., Ediger, T. R., Sun, J., Ekena, K., Lazennec, G., Martini, P. G. V., McInerney, E. M., Delage-Mourroux, R., Weis, K. E., et al. (2000) · PubMed · Cited by 202 · see citing works
Johansson, L., Rudling, M. J., Scanlan, T. S., Lundåsen, T., Webb, P., Baxter, J. D., Angelin, B., & Parini, P. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504379102 · Cited by 200 · see citing works
Self-citationBerkenstam, A. L., Kristensen, J. D., Mellström, K., Carlsson, B., Malm, J., Rehnmark, S., Garg, N. K., Andersson, C., Rudling, M. J., Sjöberg, F., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705286104 · Cited by 191 · see citing works
Self-citationHormone Selectivity in Thyroid Hormone Receptors
Wagner, R., Huber, B. R., Shiau, A. K., Kelly, A. E., Lima, S. T. D. C., Scanlan, T. S., Apriletti, J. W., Baxter, J. D., West, B. L., & Fletterick, R. J. (2001) · Molecular Endocrinology · doi:10.1210/mend.15.3.0608 · Cited by 167 · see citing works
Self-citationGrover, G. J., Egan, D. M., Sleph, P. G., Beehler, B. C., Chiellini, G., Nguyen, N.-H., Baxter, J. D., & Scanlan, T. S. (2004) · Endocrinology · doi:10.1210/en.2003-0973 · Cited by 161 · see citing works
Self-citationThyroid hormone (T3) and TRβ agonist GC‐1 inhibit/reverse nonalcoholic fatty liver in rats
Perra, A., Simbula, G., Simbula, M., Pibiri, M., Kowalik, M. A., Sulas, P., Cocco, M. T., Ledda‐Columbano, G. M., & Columbano, A. (2008) · The FASEB Journal · doi:10.1096/fj.08-108464 · Cited by 147 · see citing works
Yen, P. M., Feng, X., Flamant, F., Chen, Y., Walker, R. L., Weiss, R. E., Chassande, O., Samarut, J., Refetoff, S., & Meltzer, P. S. (2003) · EMBO Reports · doi:10.1038/sj.embor.embor862 · Cited by 123 · see citing works
Thyroid Hormone Receptor-Dependent Transcriptional Regulation of Fibrinogen and Coagulation Proteins
Shih, C., Chen, S. L., Yen, C.-C., Huang, Y., Chen, C.-D., Lee, Y., & Lin, K. (2004) · Endocrinology · doi:10.1210/en.2003-1372 · Cited by 114 · see citing works
Baxter, J. D., Webb, P., Grover, G. J., & Scanlan, T. S. (2004) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2004.03.008 · Cited by 109 · see citing works
Self-citationBryzgalova, G., Effendic, S., Khan, A., Rehnmark, S., Barbounis, P., Boulet, J., Dong, G., Singh, R., Shapses, S., Malm, J., et al. (2008) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2008.06.010 · Cited by 94 · see citing works
Self-citationNovel arylpyrazole compounds selectively modulate glucocorticoid receptor regulatory activityPreprint
Wang, J.-C., Shah, N., Pantoja, C., Meijsing, S. H., Ho, J. D., Scanlan, T. S., & Yamamoto, K. R. (2006) · Genes & Development · doi:10.1101/gad.1400506 · Cited by 94 · see citing works
Gaining ligand selectivity in thyroid hormone receptors via entropy
Martı́nez, L., Nascimento, A. S., Nunes, F. M., Phillips, K. J., Aparício, R., Dias, S. M. G., Figueira, A. C. M., Lin, J. Z., Nguyen, P. T., Apriletti, J. W., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911024106 · Cited by 84 · see citing works
Self-citationChan, I. H., & Privalsky, M. L. (2009) · Molecular Endocrinology · doi:10.1210/me.2009-0025 · Cited by 82 · see citing works
Selective modulation of promoter recruitment and transcriptional activity of PPARγ
Sears, D. D., Hsiao, A., Ofrecio, J. M., Chapman, J., He, W., & Olefsky, J. M. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.10.057 · Cited by 70 · see citing works
Quantitative Proteomics of the Thyroid Hormone Receptor-Coregulator Interactions
Moore, J. M. R., Galicia, S., McReynolds, A. C., Nguyen, N.-H., Scanlan, T. S., & Guy, R. K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403453200 · Cited by 65 · see citing works
Grijota-Martínez, C., Samarut, É., Scanlan, T. S., Morte, B., & Bernal, J. (2011) · Endocrinology · doi:10.1210/en.2010-0813 · Cited by 62 · see citing works
Zandieh‐Doulabi, B., Schiphorst, M. P.-T., van Beeren, H. C., Labruyère, W. T., Lamers, W. H., Fliers, E., Bakker, O., & Wiersinga, W. M. (2002) · Endocrinology · doi:10.1210/endo.143.3.8706 · Cited by 59 · see citing works
A TRβ-selective agonist confers resistance to diet-induced obesity
Amorim, B. S., Ueta, C. B., Freitas, B. C. G., Nassif, R. J., Gouveia, C. H. D. A., Christoffolete, M. A., Moriscot, A. S., Lancelloti, C. L., Llimona, F., Barbeiro, H. V., et al. (2009) · Journal of Endocrinology · doi:10.1677/joe-08-0539 · Cited by 54 · see citing works
Norris, J. D., Joseph, J. D., Sherk, A. B., JUZUMIENE, D. I., Turnbull, P., Rafferty, S. W., Cui, H. N., Anderson, E. L., Fan, D., Dye, D. A., et al. (2009) · Chemistry & Biology · doi:10.1016/j.chembiol.2009.01.016 · Cited by 52 · see citing works
Drover, V. A. B., & Agellon, L. B. (2003) · Endocrinology · doi:10.1210/en.2003-0993 · Cited by 52 · see citing works
Togashi, M., Borngraeber, S., Sandler, B., Fletterick, R. J., Webb, P., & Baxter, J. D. (2005) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2005.01.004 · Cited by 52 · see citing works
Self-citationGloss, B. R., Giannocco, G., Swanson, E. A., et al. (2005) · Endocrinology · doi:10.1210/en.2005-0631 · Cited by 49 · see citing works
Nuclear receptors in disease: the oestrogen receptors
Nilsson, M., Dahlman‐Wright, K., & Gustafsson, J.-Α. (2004) · Essays in Biochemistry · doi:10.1042/bse0400157 · Cited by 30 · see citing works
Castillo, M., Freitas, B. C. G., Rosene, M. L., Drigo, R. A., Grozovsky, R., Maciel, R. M. B., Patti, M. E., Ribeiro, M. O., & Bianco, A. C. (2010) · Thyroid · doi:10.1089/thy.2009.0318 · Cited by 28 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Bianco, A. C., Anderson, G., Forrest, D., Galton, V. A., Gereben, B., Kim, B. W., Kopp, P. A., Liao, X. H., Obregon, M. J., Peeters, R. P., et al. (2014) · Thyroid · doi:10.1089/thy.2013.0109 · Cited by 205 · see citing works
Novel therapeutic targets for cholestatic and fatty liver disease
Trauner, M., & Fuchs, C. D. (2022) · Gut · doi:10.1136/gutjnl-2021-324305 · Cited by 204 · see citing works
An extended transcription factor regulatory network controls hepatocyte identity
Dubois‐Chevalier, J., Gheeraert, C., Berthier, A., Boulet, C., Dubois, V., Guille, L., Fourcot, M., Marot, G., Gauthier, K., Dubuquoy, L., et al. (2023) · EMBO Reports · doi:10.15252/embr.202357020 · Cited by 6 · see citing works
- Authors
- Yuan, C., Lin, J. Z. H., Sieglaff, D. H., Ayers, S. D., DeNoto-Reynolds, F., Baxter, J. D., & Webb, P.
- Affiliations
- Houston Methodist (US)
- Diabetes Center and Department of Medicine (C.Y., F.D.R., J.D.B.), University of California, San Francisco, California 94122
- Corresponding author
- Webb, Paul
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2012-01-01
- Volume
- 153
- Issue
- 1
- Pages
- 501-511
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- PMC
- PMC3249679
- OpenAlex
- W2075858435
- Cited by
- 70
- References
- 35
- Citations by year
- 2025: 26 · 2024: 1 · 2023: 3 · 2022: 1 · 2021: 5 · 2020: 2 · 2018: 1 · 2017: 5 · 2016: 4 · 2015: 2 · 2014: 7 · 2013: 10 · 2012: 3
- FWCI
- 5.51
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Endocrinology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (NIH-R01)
- National Institute of Diabetes and Digestive and Kidney Diseases (RC4DK090849, DK61468, DK090849-01)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Estrogen and related hormone effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Keywords
- GC-1, triiodothyronine, thyroid hormone receptor beta, hepatic gene expression, HepG2 cells, hypothyroidism, dyslipidemia, nuclear receptor ligands
- MeSH terms
- Angiopoietin-Like Protein 4, Acetates, Animals, Binding Sites, Gene Expression Regulation, Humans, Liver, Male, Mice, Inbred C57BL, Phenols, Receptors, Thyroid Hormone, Triiodothyronine, RNA, Small Interfering, Thyroid Hormone Receptors alpha, Thyroid Hormone Receptors beta, Angiopoietins, Mice, Hep G2 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review